We’re pleased to announce a collaboration with Prof. Tao Wang at The University of Manchester to explore disease mechanisms and vascular factors that contribute to the development of amyotrophic lateral sclerosis (ALS). This proposal to leverage cutting-edge technologies like CRISPR gene editing and 3D brain tissue models promises to advance our understanding of ALS to help researchers develop new treatments for neurodegenerative diseases.
Alexion, AstraZeneca Rare Disease is proud to support this research through the OpenInnovation CoSolve programme. Learn more here: openinnovation.astrazeneca.com/
------------------------------------------------------------
Global site: www.astrazeneca.com/
Careers site: careers.astrazeneca.com/
Follow us:
Twitter: / astrazeneca
LinkedIn: / astrazeneca
Instagram: / astrazeneca
Facebook: / astrazeneca